A randomized phase II trial of ATN-224 in combination with temozolomide or temozolomide followed by ATN-224 in patients with advanced melanoma

Trial Profile

A randomized phase II trial of ATN-224 in combination with temozolomide or temozolomide followed by ATN-224 in patients with advanced melanoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2007

At a glance

  • Drugs Bis-choline tetrathiomolybdate (Primary) ; Temozolomide
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Sponsors Attenuon
  • Most Recent Events

    • 20 Dec 2007 Status changed from recruiting to in progress.
    • 23 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top